Stem Cell Therapeutics (SSS)

[BioSpecialist]

Positive Stroke data = 3$++ Tgt !!!!

Hold on to your shares ....


Stem Cell Therapeutics (SSS.V)
Market Cap 41 Mio $
Price 0,30 $


UPCOMING MILESTONES

Complete recruiting for modified REGENESIS Phase IIb clinical stroke trial end of Q1 10

Top-line read of modified REGENESIS Phase IIb stroke trial data
end of Q2 10

Initiate and enrol patients in a Phase IIa clinical study for traumatic brain injury H1 10


Initiate clinical Proof-of-Concept study for multiple sclerosis 2010